explore -WSS

explore

author：leisure time 2025-09-30 20:06:26 - browse：39179

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

hotspot

WSS

Alnylam reports growth in sales of rare disease treatments

Thermo Fisher plant for manufacturing gene therapies to expand

Alnylam reports growth in sales of rare disease treatments

Medicare slashes safety net hospital payments by nearly $1 billion

Thermo Fisher plant for manufacturing gene therapies to expand

CommonSpirit Health keeps growing, even as it loses money

focus

explore

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

FDA approves Sage Therapeutics’ rapid

Peter Hotez and the public health issue of online harassment

Personalized medicine goes far beyond genetics

Moonlake's readout produced a cash windfall. Risks remain

Medical student insurance fails on mental health care coverage

Psychedelics group wrestles with new pharma identity

How AI helped researchers track recovery from depression

Medical records are filled with copy

Thermo Fisher plant for manufacturing gene therapies to expand

focus

Senate HELP committee spars over health care workforce policies

CDC recommends RSV monoclonal antibody for infants

Flint parents haunted by uncertainty, fears of lead poisoning

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

When waiting feels immoral: Empathy in the emergency department

FDA panel to weigh approval of NurOwn, controversial ALS drug

focus

entertainment

hotspot

hotspot